Pharmaceuticals
BioMarin Pharmaceutical Is Ready to Start a Fresh Advance
Here's where aggressive traders could go long BMRN.
Zoetis Could Be Seeing Its Correction Coming to an End
The shares of the animal health company could be finding a bottom after losing substantial ground since the start of the year.
CVS Is a Good Place to Hide in a Volatile Marketplace: What Traders Can Do
The firm certainly seems to have the wind at its sails right now.
Walgreens Boots Alliance Is Ready to Break Out of Its Lengthy Consolidation
Here's where traders could go long.
Caution Signs Are Flashing in My Mind as the New Year Begins
The biotech sector looks ripe for staging a comeback, but a significant geopolitical event could throw the entire market for a loop.
Options Play of the Week: Take a Chance on This Small Biopharma in 2022
After a huge drop in recent weeks, these shares look oversold -- and an insider seems to agree.
Gilead Sciences Is Poised for Still Further Gains
We have three new price targets.
Amgen's Charts Continue to Strengthen
This rally could surprise on the upside.
I Don't Love Biogen, But Here's How to Trade It
I'm not saying get married to the stock, I'm saying that the idea could be a trade based on two possible catalysts.
So Far, So Good for This Portfolio of Unloved Losers
Most of the stocks in the 2022 Tax Loss Selling Recovery Portfolio are in positive territory nearly a month since inception.